Zobrazeno 1 - 10
of 435
pro vyhledávání: '"Joji Suzuki"'
Publikováno v:
Addictive Behaviors Reports, Vol 19, Iss , Pp 100546- (2024)
Introduction: Individuals with opioid use disorder (OUD) who inject drugs have an elevated risk of experiencing serious injection-related infections. While such infections can be treated, treatment for the underlying OUD is often limited. One potenti
Externí odkaz:
https://doaj.org/article/fdd43f3e2ba74759bf5c03fe63223a86
Autor:
Joji Suzuki, Frank Loguidice, Sara Prostko, Veronica Szpak, Samata Sharma, Lisa Vercollone, Carol Garner, David Ahern
Publikováno v:
JMIR Formative Research, Vol 7, p e43304 (2023)
BackgroundAlcohol use disorder (AUD), associated with significant morbidity and mortality, continues to be a major public health problem. The COVID-19 pandemic exacerbated the impact of AUD, with a 25% increase in alcohol-related mortality from 2019
Externí odkaz:
https://doaj.org/article/69231a9eb26e44c7a993edd705f746fc
Publikováno v:
Integrative Medicine Reports, Vol 1, Iss 1, Pp 157-163 (2022)
Background: Opioid use disorder (OUD) remains a major public health concern. Despite the use of medications for OUD such as buprenorphine, the current gold-standard treatment, relapse in the context of increased craving remains common. Cannabidiol (C
Externí odkaz:
https://doaj.org/article/9a370676621e4f8db03cff958a0355ea
Autor:
Charlotte E. Goldfine, Jeremiah J. Tom, Dana D. Im, Benjamin Yudkoff, Amit Anand, Joseph J. Taylor, Peter R. Chai, Joji Suzuki
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
IntroductionAlcohol use disorder (AUD) is the most prevalent substance use disorder (SUD) globally. In 2019, AUD affected 14.5 million Americans and contributed to 95,000 deaths, with an annual cost exceeding 250 billion dollars. Current treatment op
Externí odkaz:
https://doaj.org/article/e0c8f5a0b1ae4051a4e4530d9f78cc62
Autor:
Joji Suzuki, Sara Prostko, Veronica Szpak, Peter R. Chai, Primavera A. Spagnolo, Ruth E. Tenenbaum, Saeed Ahmed, Roger D. Weiss
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
IntroductionOpioid use disorder (OUD) continues to be a significant public health concern. Medications for OUD (MOUD) such as buprenorphine reduce overdose mortality, but relapses occur often, leading to adverse outcomes. Preliminary data suggest tha
Externí odkaz:
https://doaj.org/article/c463f0333739406b8d990cb0167044a1
Publikováno v:
JMIR Formative Research, Vol 6, Iss 7, p e38684 (2022)
BackgroundIn recent years, there has been increasing interest in implementing digital technologies to diagnose, monitor, and intervene in substance use disorders. Smartphones are now a vehicle for facilitating telepsychiatry visits, measuring health
Externí odkaz:
https://doaj.org/article/16662cc5a6404a1b86c5c69651400552
Autor:
June-Ho Kim, Danielle R Fine, Lily Li, Simeon D Kimmel, Long H Ngo, Joji Suzuki, Christin N Price, Matthew V Ronan, Shoshana J Herzig
Publikováno v:
PLoS Medicine, Vol 17, Iss 8, p e1003247 (2020)
BackgroundPatients with opioid use disorder (OUD) who are hospitalized for serious infections requiring prolonged intravenous antibiotics may face barriers to discharge, which could prolong hospital length of stay (LOS) and increase financial burden.
Externí odkaz:
https://doaj.org/article/89e31d86a4ea4197aa920c6691f6c8ed
Autor:
Peter D. Friedmann, Joji Suzuki
Publikováno v:
Addiction Science & Clinical Practice, Vol 12, Iss 1, Pp 1-3 (2017)
Externí odkaz:
https://doaj.org/article/1b1db9d5ef3c44288c591704167d87d1
Autor:
Claudia P. Rodriguez, Joji Suzuki
Publikováno v:
The American Journal on Addictions. 32:314-317
Autor:
Joji Suzuki, Bianca Martin, Frank Loguidice, David Smelson, Jane M. Liebschutz, Jeffrey L. Schnipper, Roger D. Weiss
Publikováno v:
Journal of Addiction Medicine.